OTCMKTS:RBCL - RBC Life Sciences Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$0.15 0.00 (0.00 %)
(As of 11/13/2018 03:54 PM ET)
Previous Close$0.1501
Today's Range$0.15 - $0.15
52-Week Range$0.1157 - $0.4711
VolumeN/A
Average Volume1,200 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Beta-1.12
RBC Life Sciences, Inc. manufactures, markets, and distributes nutritional supplements and personal care products in North America, Southeast Asia, and Australia. The company's Nutritional Products segment offers nutritional supplements and personal care products, including herbs, vitamins, and minerals; and natural skin, hair, and body care products through a network of independent distributors and license arrangements. Its products include Stem-Kine, a dietary supplement; Microhydrin and Microhydrin Plus antioxidants; VitAloe, a blend of research-backed ingredients; OliViva, an antioxidant beverage to support immune and cardiovascular system; Organic Spirulina, a nutritious alga that provides range of nutrients and easily digested proteins; and NeuroBright to support brain function, and enhance energy and acuity. This segments products also comprise Colo-Vada Plus, a colon cleansing program; HydraCel to enhance the quality of drinking water; 24 Seven, a multivitamin/mineral supplement; Immune 360 to nourish and support the function of the immune system; and Aloe Gelee gel that provides the soothing and moisturizing. Its Medical Products segment offers wound care products for the treatment and healing of wounds, such as pressure ulcers, leg ulcers, cuts, burns, and abrasions. Its products include cleansers, dressings, hydrogels, collagen, calcium alginates, moisture barriers, antimicrobials, and a hydrogel wound dressing with Lidocaine. This segment also offers other wound care products designed to reduce destruction to skin and tissue caused by radiation; and to reduce pain and itching in the skin, and the internal mucosa caused by radiation reactions or reactions to various cancer medications. This segment sells its products under the MPM Medical brand to hospitals, nursing homes, clinics, and pharmacies through a network of medical/surgical supply dealers and pharmaceutical distributors. The company was founded in 1988 and is headquartered in Irving, Texas.

Receive RBCL News and Ratings via Email

Sign-up to receive the latest news and ratings for RBCL and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Miscellaneous nondurable goods
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:RBCL
Previous Symbol
CUSIPN/A
Phone972-893-4000

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding Shares2,210,000
Market Cap$0.00
OptionableNot Optionable

RBC Life Sciences (OTCMKTS:RBCL) Frequently Asked Questions

What is RBC Life Sciences' stock symbol?

RBC Life Sciences trades on the OTCMKTS under the ticker symbol "RBCL."

Has RBC Life Sciences been receiving favorable news coverage?

Headlines about RBCL stock have been trending somewhat positive this week, InfoTrie Sentiment reports. The research firm identifies positive and negative news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. RBC Life Sciences earned a media sentiment score of 1.4 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the company's share price in the near future.

Who are some of RBC Life Sciences' key competitors?

Who are RBC Life Sciences' key executives?

RBC Life Sciences' management team includes the folowing people:
  • Mr. Clinton H. Howard, Founder & Chairman (Age 90)
  • Mr. Steven E. Brown, Pres, Chief Exec. Officer & Director (Age 63)
  • Mr. Douglas R. Wheeler, VP of Operations (Age 45)
  • Mr. Don Clark, Chief Information Officer
  • Ms. Carolyn Rachaner, VP of Marketing & Product Devel.

How do I buy shares of RBC Life Sciences?

Shares of RBCL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is RBC Life Sciences' stock price today?

One share of RBCL stock can currently be purchased for approximately $0.15.

What is RBC Life Sciences' official website?

The official website for RBC Life Sciences is http://www.rbclifesciences.com.

How can I contact RBC Life Sciences?

RBC Life Sciences' mailing address is 2301 CROWN COURT, IRVING TX, 75038. The company can be reached via phone at 972-893-4000 or via email at [email protected]


MarketBeat Community Rating for RBC Life Sciences (OTCMKTS RBCL)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  28 (Vote Outperform)
Underperform Votes:  32 (Vote Underperform)
Total Votes:  60
MarketBeat's community ratings are surveys of what our community members think about RBC Life Sciences and other stocks. Vote "Outperform" if you believe RBCL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RBCL will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/13/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel